Perinatal hypoxia-ischemia reduces α 7 nicotinic receptor expression and selective α 7 nicotinic receptor stimulation suppresses inflammation and promotes microglial Mox phenotype

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Hua, Sansan ^a   Ek, C Joakim ^a   Mallard, Carina ^a   Johansson, Maria E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CD 206 ANTIGEN; CD86 ANTIGEN; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN; NICOTINIC AGENT; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD86 PROTEIN, MOUSE; CELL SURFACE RECEPTOR; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; NOS2 PROTEIN, MOUSE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG DOSE INCREASE; GENE EXPRESSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; INFLAMMATION; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STIMULATION; AGONISTS; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; PATHOLOGY;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD86; GENE EXPRESSION REGULATION; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CELL SURFACE;

EID: 84897493640     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/718769     Document Type: Article

References (42)

1. Perez A., Ritter S., Brotschi B., Werner H., Caflisch J., Martin E., Latal B., Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy. Journal of Pediatrics 2013 163 454 459
2. Dammann O., Leviton A., Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Human Development 2004 79 1 1 15 2-s2.0-3843060550 10.1016/j.earlhumdev.2004.04.009 (Pubitemid 39036744)
3. Hedtjärn M., Mallard C., Hagberg H., Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. Journal of Cerebral Blood Flow and Metabolism 2004 24 12 1333 1351 2-s2.0-10944268615 10.1097/00004647- 200412000-00003 (Pubitemid 40019157)
4. Vexler Z. S., Tang X. N., Yenari M. A., Inflammation in adult and neonatal stroke. Clinical Neuroscience Research 2006 6 5 293 313 2-s2.0-33845337987 10.1016/j.cnr.2006.09.008 (Pubitemid 44872641)
5. Hedtjärn M., Leverin A.-L., Eriksson K., Blomgren K., Mallard C., Hagberg H., Interleukin-18 involvement in hypoxic-ischemic brain injury. The Journal of Neuroscience 2002 22 14 5910 5919 2-s2.0-0037101645 (Pubitemid 35387635)
6. Svedin P., Hagberg H., Sävman K., Zhu C., Mallard C., Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. The Journal of Neuroscience 2007 27 7 1511 1518 2-s2.0-33847092562 10.1523/JNEUROSCI.4391-06.2007 (Pubitemid 46280068)
7. Vexler Z. S., Yenari M. A., Does inflammation after stroke affect the developing brain differently than adult brain? Developmental Neuroscience 2009 31 5 378 393 2-s2.0-68349098877 10.1159/000232556
8. Leitinger N., Schulman I. G., Phenotypic polarization of macrophages in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 33 1120 1126
9. Sica A., Mantovani A., Macrophage plasticity and polarization: in vivo veritas. Journal of Clinical Investigation 2012 122 3 787 795 2-s2.0-84857883847 10.1172/JCI59643
10. Kadl A., Meher A. K., Sharma P. R., Lee M. Y., Doran A. C., Johnstone S. R., Elliott M. R., Gruber F., Han J., Chen W., Kensler T., Ravichandran K. S., Isakson B. E., Wamhoff B. R., Leitinger N., Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circulation Research 2010 107 6 737 746 2-s2.0-77957260181 10.1161/CIRCRESAHA. 109.215715
11. Gleissner C. A., Shaked I., Little K. M., Ley K., CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. Journal of Immunology 2010 184 9 4810 4818 2-s2.0-77954507872 10.4049/jimmunol.0901368
12. Chhor V., Le Charpentier T., Lebon S., Ore M. V., Celador I. L., Josserand J., Degos V., Jacotot E., Hagberg H., Savman K., Mallard C., Gressens P., Fleiss B., Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain, Behavior, and Immunity 2013 32 70 85
13. Albuquerque E. X., Alkondon M., Pereira E. F. R., Castro N. G., Schrattenholz A., Barbosa C. T. F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H. M., Maelicke A., Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. Journal of Pharmacology and Experimental Therapeutics 1997 280 3 1117 1136 2-s2.0-0005994352 (Pubitemid 27166705)
14. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., Akaike A., α 7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β -Amyloid-induced Neurotoxicity. The Journal of Biological Chemistry 2001 276 17 13541 13546 2-s2.0-0035957946
15. Zoli M., Picciotto M. R., Ferrari R., Cocchi D., Changeux J.-P., Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO Journal 1999 18 5 1235 1244 2-s2.0-0033104499 (Pubitemid 29110308)
16. Burghaus L., Schütz U., Krempel U., De Vos R. A. I., Jansen Steur E. N. H., Wevers A., Lindstrom J., Schröder H., Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Molecular Brain Research 2000 76 2 385 388 2-s2.0-0034728596 10.1016/S0169-328X(00)00031-0 (Pubitemid 30179776)
17. Guan Z.-Z., Nordberg A., Mousavi M., Rinne J. O., Hellström-Lindahl E., Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Research 2002 956 2 358 366 2-s2.0-0037195553 10.1016/S0006-8993(02)03571-0 (Pubitemid 35351403)
18. Freedman R., Olincy A., Buchanan R. W., Harris J. G., Gold J. M., Johnson L., Allensworth D., Guzman-Bonilla A., Clement B., Ball M. P., Kutnick J., Pender V., Martin L. F., Stevens K. E., Wagner B. D., Zerbe G. O., Soti F., Kem W. R., Initial phase 2 trial of a nicotinic agonist in schizophrenia. American Journal of Psychiatry 2008 165 8 1040 1047 2-s2.0-48949099564 10.1176/appi.ajp.2008.07071135
19. Olincy A., Harris J. G., Johnson L. L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G. O., Leonard S., Stevens K. E., Stevens J. O., Martin L., Adler L. E., Soti F., Kem W. R., Freedman R., Proof-of-concept trial of an α 7 nicotinic agonist in schizophrenia. Archives of General Psychiatry 2006 63 6 630 638 2-s2.0-33744911665 10.1001/archpsyc.63.6.630 (Pubitemid 43848294)
20. Wang H., Yu M., Ochani M., Amelia C. A., Tanovic M., Susarla S., Li J. H., Wang H., Yang N., Ulloa L., Al-Abed Y., Czura C. J., Tracey K. J., Nicotinic acetylcholine receptor α 7 subunit is an essential regulator of inflammation. Nature 2003 421 6921 384 388 2-s2.0-0037461768 10.1038/nature01339 (Pubitemid 36157937)
21. Andersson U., Tracey K. J., Neural reflexes in inflammation and immunity. The Journal of Experimental Medicine 2012 209 1057 1068
22. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E. J., Tracey K. J., Ulloa L., Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 2004 10 11 1216 1221 2-s2.0-9144263639 10.1038/nm1124 (Pubitemid 39540438)
23. Parada E., Egea J., Buendia I., Negredo P., Cunha A. C., Cardoso S., Soares M. P., Lopez M. G., The microglial alpha7-acetylcholine nicotinic receptor Is a key element in promoting neuroprotection by Inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxidants & Redox Signaling 2013 19 1135 1148
24. Shytle R. D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A. A., Sanberg P. R., Tan J., Cholinergic modulation of microglial activation by α 7 nicotinic receptors. Journal of Neurochemistry 2004 89 2 337 343 2-s2.0-11144355227 10.1046/j.1471-4159.2004.02347.x (Pubitemid 38495982)
25. Suzuki T., Hide I., Matsubara A., Hama C., Harada K., Miyano K., Andrä M., Matsubayashi H., Sakai N., Kohsaka S., Inoue K., Nakata Y., Microglial α 7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. Journal of Neuroscience Research 2006 83 8 1461 1470 2-s2.0-33744920090 10.1002/jnr.20850 (Pubitemid 43844991)
26. Stridh L., Mottahedin A., Johansson M. E., Valdez R. C., Northington F., Wang X., Mallard C., Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. The Journal of Neuroscience 2013 33 12041 12051 10.1523/JNEUROSCI.0673-13.2013
27. Craig A., Luo N. L., Beardsley D. J., Wingate-Pearse N., Walker D. W., Hohimer A. R., Back S. A., Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Experimental Neurology 2003 181 2 231 240 2-s2.0-0038054471 10.1016/S0014-4886(03)00032-3 (Pubitemid 36629244)
28. Leonard S., Breese C., Adams C., Benhammou K., Gault J., Stevens K., Lee M., Adler L., Olincy A., Ross R., Freedman R., Smoking and schizophrenia: abnormal nicotinic receptor expression. European Journal of Pharmacology 2000 393 1-3 237 242 2-s2.0-0034732116 10.1016/S0014-2999(00)00035-2 (Pubitemid 30193422)
29. Verbois S. L., Scheff S. W., Pauly J. R., Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury. Journal of Neurotrauma 2002 19 12 1569 1585 2-s2.0-0036926718 (Pubitemid 36026213)
30. Verbois S. L., Scheff S. W., Pauly J. R., Chronic nicotine treatment attenuates α 7 nicotinic receptor deficits following traumatic brain injury. Neuropharmacology 2003 44 2 224 233 2-s2.0-0344089297 10.1016/S0028-3908(02)00366-0
31. Buisson B., Bertrand D., Nicotine addiction: the possible role of functional upregulation. Trends in Pharmacological Sciences 2002 23 3 130 136 2-s2.0-0036499938 10.1016/S0165-6147(00)01979-9 (Pubitemid 34185414)
32. Liu Q., Tang Z., Gan Y., Wu W., Kousari A., La Cava A., Shi F. D., Genetic deficiency of beta2-containing nicotinic receptors attenuates brain injury in ischemic stroke. Neuroscience 2014 256 170 177 10.1016/j.neuroscience. 2013.10.049
33. Timmermann D. B., Sandager-Nielsen K., Dyhring T., Smith M., Jacobsen A. M., Nielsen E. O., Grunnet M., Christensen J. K., Peters D., Kohlhaas K., Olsen G. M., Ahring P. K., Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha2- and alpha4-containing nicotinic acetylcholine receptors. British Journal of Pharmacology 2012 167 164 182
34. Christensen D. Z., Mikkelsen J. D., Hansen H. H., Thomsen M. S., Repeated administration of 7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases 7 nAChR levels in the brain. Journal of Neurochemistry 2010 114 4 1205 1216 2-s2.0-77954755620 10.1111/j.1471-4159. 2010.06845.x
35. Thomsen M. S., Mikkelsen J. D., Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of alpha7 nicotinic acetylcholine receptors. Journal of Neurochemistry 2012 123 73 83
36. Kume T., Sugimoto M., Takada Y., Yamaguchi T., Yonezawa A., Katsuki H., Sugimoto H., Akaike A., Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. European Journal of Pharmacology 2005 527 1-3 77 85 2-s2.0-28544434902 10.1016/j.ejphar.2005.10.028 (Pubitemid 41745154)
37. Brooks N. P., Mexal S., Stitzel J. A., Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels. Brain Research 2009 1263 1 9 2-s2.0-61849169563 10.1016/j.brainres.2009.01.026
38. Chatterjee P. K., Al-Abed Y., Sherry B., Metz C. N., Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. American Journal of Physiology: Cell Physiology 2009 297 5 C1294 C1306 2-s2.0-70449635663 10.1152/ajpcell.00160.2009
39. de Jonge W. J., van der Zanden E. P., The F. O., Bijlsma M. F., van Westerloo D. J., Bennink R. J., Berthoud H.-R., Uematsu S., Akira S., van den Wijngaard R. M., Boeckxstaens G. E., Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nature Immunology 2005 6 8 844 851 2-s2.0-23844454674 10.1038/ni1229 (Pubitemid 43090471)
40. Toborek M., Son K. W., Pudelko A., King-Pospisil K., Wylegala E., Malecki A., ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. Journal of Cellular Biochemistry 2007 100 2 279 292 2-s2.0-33846423514 10.1002/jcb.21013 (Pubitemid 46146079)
41. Saeed R. W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K. J., Al-Abed Y., Metz C. N., Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. Journal of Experimental Medicine 2005 201 7 1113 1123 2-s2.0-17144370981 10.1084/jem.20040463 (Pubitemid 40524679)
42. Butcher M. J., Galkina E. V., Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Frontiers in Physiology 2012 3, article 44